Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Link opens in a new tab
Search content at UTMB Health Research Expert Profiles
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Screening methods for influenza antiviral drug discovery
Colm Atkins
, Carrie W. Evans
, E. Lucile White
, James W. Noah
Research output
:
Contribution to journal
›
Review article
›
peer-review
19
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Screening methods for influenza antiviral drug discovery'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Screening Method
100%
Antiviral Drug Discovery
100%
Influenza Antiviral
100%
Viral Targets
75%
New Drugs
50%
High-throughput Screening
50%
Primary Cells
50%
Host Target
50%
Viral Replication
25%
Targeted Therapeutics
25%
Novel Mechanism
25%
Novel Therapeutics
25%
Virus Strains
25%
Highly Pathogenic
25%
Antiviral Activity
25%
Target Interaction
25%
Compound Library
25%
Host-pathogen Interactions
25%
Physiologically Relevant
25%
High-throughput
25%
Drug Discovery
25%
Pathogenic Strains
25%
Biocontainment
25%
Host Factors
25%
Viral Isolates
25%
Multiplex Assay
25%
Expert Opinion
25%
Area Cover
25%
High Content
25%
Physiological Relevance
25%
Targeted Library
25%
Screening Effort
25%
Factor Interaction
25%
Future Innovations
25%
Real-world Examples
25%
Proximity-based
25%
Targeted Compounds
25%
Line Compound
25%
Anti-influenza Drugs
25%
Translational Applications
25%
Virus-host
25%
Non-laboratory
25%
High-throughput Screen
25%
Endpoints Method
25%
Strain Cells
25%
Author's Work
25%
Pharmacology, Toxicology and Pharmaceutical Science
Antivirus Agent
100%
Drug Discovery
100%
Influenza
100%
High-Throughput Screening
40%
Antiviral Drug
20%
Antiviral Activity
20%
Virus Strain
20%
Host Factor
20%
Biocontainment
20%
Virus
20%
Immunology and Microbiology
Influenza
100%
High Throughput Screening
40%
Viral Replication
20%
Virus Strain
20%
Antiviral Activity
20%
Host Factor
20%
Primary Cell Line
20%
Virus
20%